David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
PUT
American Express
AXP
$228B
| $1.42M | ﹤0.01% |
11,500
-40,300
| -78% | -$4.73M |
|
|
ALXN
2427
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.42M | ﹤0.01% |
10,800
+900
| +9% | +$116K |
|
|
LLL
2428
DELISTED
L3 Technologies, Inc.
LLL
| $1.42M | ﹤0.01% |
+5,773
| New | +$1.35M |
|
|
VWTR
2429
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $1.41M | ﹤0.01% |
121,668
+28,111
| +30% | +$311K |
|
|
SINA
2430
CALL
DELISTED
Sina Corp
SINA
| $1.41M | ﹤0.01% |
32,700
+28,700
| +718% | +$1.5M |
|
2431
PUT
Macerich
MAC
$6.89B
| $1.41M | ﹤0.01% |
+42,000
| New | +$1.65M |
|
|
LJPC
2432
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.4M | ﹤0.01% |
151,440
-437,181
| -74% | -$3.29M |
|
2433
Grupo Aval
AVAL
$6.48B
| $1.4M | ﹤0.01% |
175,519
+10,570
| +6% | +$80.6K |
|
|
ESPR
2434
PUT
DELISTED
Esperion Therapeutics
ESPR
| $1.4M | ﹤0.01% |
+30,000
| New | +$1.41M |
|
2435
Southside Bancshares
SBSI
$953M
| $1.39M | ﹤0.01% |
43,054
+11,566
| +37% | +$392K |
|
2436
PUT
Franco-Nevada
FNV
$51.9B
| $1.39M | ﹤0.01% |
16,400
| – | – |
|
2437
Installed Building Products
IBP
$6.52B
| $1.39M | ﹤0.01% |
+23,484
| New | +$1.24M |
|
2438
PUT
Nutanix
NTNX
$17.8B
| $1.39M | ﹤0.01% |
+53,500
| New | +$1.86M |
|
2439
Chubb
CB
$133B
| $1.39M | ﹤0.01% |
9,406
+4,362
| +86% | +$630K |
|
2440
PUT
Under Armour
UAA
$2.22B
| $1.38M | ﹤0.01% |
54,500
| – | – |
|
|
CRR
2441
DELISTED
Carbo Ceramics Inc.
CRR
| $1.38M | ﹤0.01% |
1,022,932
+17,184
| +2% | +$37.9K |
|
2442
PUT
Molson Coors Class B
TAP
$7.86B
| $1.38M | ﹤0.01% |
24,600
-5,900
| -19% | -$344K |
|
|
BITA
2443
DELISTED
Bitauto Holdings Limited
BITA
| $1.38M | ﹤0.01% |
131,568
+109,095
| +485% | +$1.32M |
|
2444
ICF International
ICFI
$1.6B
| $1.38M | ﹤0.01% |
18,903
-7,357
| -28% | -$551K |
|
2445
InterContinental Hotels
IHG
$24.3B
| $1.37M | ﹤0.01% |
+20,518
| New | +$1.34M |
|
2446
PUT
J.M. Smucker
SJM
$14B
| $1.37M | ﹤0.01% |
11,900
-2,100
| -15% | -$256K |
|
2447
Thor Industries
THO
$4.06B
| $1.37M | ﹤0.01% |
23,400
-14,275
| -38% | -$866K |
|
|
QTT
2448
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
| $1.37M | ﹤0.01% |
+34,729
| New | +$2.2M |
|
2449
Accenture
ACN
$111B
| $1.37M | ﹤0.01% |
7,400
-4,632
| -38% | -$832K |
|
|
FOCS
2450
PUT
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.37M | ﹤0.01% |
+50,000
| New | +$1.63M |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.